• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-194通过靶向H9c2细胞中的CnA/NFATc2信号通路抑制异丙肾上腺素诱导的慢性心脏肥大。

MicroRNA-194 inhibits isoproterenol-induced chronic cardiac hypertrophy via targeting CnA/NFATc2 signaling in H9c2 cells.

作者信息

Wang Jian, An Yucheng, Lin Jun, Tang Gang

机构信息

Department of Cardiology, The Third Affiliated Hospital of Chongqing Medical University (Jieer Hospital), Chongqing, China.

出版信息

Ann Transl Med. 2022 Jul;10(14):780. doi: 10.21037/atm-22-1894.

DOI:10.21037/atm-22-1894
PMID:35965805
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9372657/
Abstract

BACKGROUND

This study explored the effects of microRNA(miR)-194 on chronic cardiac hypertrophy (CH) induced by isoproterenol (ISO). The potential mechanism through regulation of the calcineurin A (CnA)/nuclear factor of activated T cells (NFAT) c2 pathway was investigated in the rat cardiomyoblast cell line H9c2.

METHODS

H9c2 cells were treated with ISO to induce cardiomyocyte hypertrophy to simulate CH . The cell surface area was assessed by phalloidin staining. The expression of miR-194, CnA mRNA, and CnA protein were assessed. Furthermore, the cellular localization of the NFATc2 protein after induction of CH was detected. The relationship between miR-194 and the CnA mRNA 3'-untranslated region (UTR) was verified by dual luciferase report assays. By constructing cardiomyocyte cell models with low expression of miR-194 and/or CnA, the effects of miR-194 and CnA on the localization of the NFATc2 protein and cell hypertrophy was investigated. Rescue experiments were conducted to analyze whether overexpression of miR-194 could alleviate the cell hypertrophy induced by ISO.

RESULTS

The results demonstrated that induction with ISO significantly increased the surface area of H9c2 cells. After induction, the expression of miR-194 decreased, while both CnA mRNA and protein expression increased. Furthermore, the nuclear translocation of NFATc2 was obvious. MiR-194 bound to the 3'-UTR of CnA mRNA and inhibited CnA protein expression. Inhibition of miR-194 expression activated NFATc2 protein expression and increased the H9c2 cell surface area. After CnA expression was disturbed, hypertrophy induced by miR-194 down-regulation was blocked. In addition, overexpression of miR-194 significantly alleviated cell hypertrophy and activation of the CnA/NFATc2 pathway caused by ISO.

CONCLUSIONS

In conclusion, increasing the expression of miR-194 can alleviate CH by targeting can and inhibiting the CnA/NFATc2 pathway.

摘要

背景

本研究探讨了微小RNA(miR)-194对异丙肾上腺素(ISO)诱导的慢性心肌肥厚(CH)的影响。在大鼠心肌成纤维细胞系H9c2中研究了其通过调节钙调神经磷酸酶A(CnA)/活化T细胞核因子(NFAT)c2途径的潜在机制。

方法

用ISO处理H9c2细胞以诱导心肌细胞肥大来模拟CH。通过鬼笔环肽染色评估细胞表面积。评估miR-194、CnA mRNA和CnA蛋白的表达。此外,检测CH诱导后NFATc2蛋白的细胞定位。通过双荧光素酶报告基因检测验证miR-194与CnA mRNA 3'-非翻译区(UTR)之间的关系。通过构建miR-194和/或CnA低表达的心肌细胞模型,研究miR-194和CnA对NFATc2蛋白定位和细胞肥大的影响。进行挽救实验以分析miR-194过表达是否能减轻ISO诱导的细胞肥大。

结果

结果表明,ISO诱导显著增加了H9c2细胞的表面积。诱导后,miR-194表达降低,而CnA mRNA和蛋白表达均增加。此外,NFATc2的核转位明显。miR-194与CnA mRNA的3'-UTR结合并抑制CnA蛋白表达。抑制miR-194表达激活了NFATc2蛋白表达并增加了H9c2细胞表面积。CnA表达受干扰后,miR-194下调诱导的肥大被阻断。此外,miR-194过表达显著减轻了ISO引起的细胞肥大和CnA/NFATc2途径的激活。

结论

总之,增加miR-194的表达可通过靶向CnA并抑制CnA/NFATc2途径来减轻CH。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e72/9372657/4894b31d583e/atm-10-14-780-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e72/9372657/4e6c075ce529/atm-10-14-780-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e72/9372657/daf7dae5cf6c/atm-10-14-780-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e72/9372657/02590a1d200a/atm-10-14-780-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e72/9372657/4894b31d583e/atm-10-14-780-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e72/9372657/4e6c075ce529/atm-10-14-780-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e72/9372657/daf7dae5cf6c/atm-10-14-780-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e72/9372657/02590a1d200a/atm-10-14-780-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e72/9372657/4894b31d583e/atm-10-14-780-f4.jpg

相似文献

1
MicroRNA-194 inhibits isoproterenol-induced chronic cardiac hypertrophy via targeting CnA/NFATc2 signaling in H9c2 cells.微小RNA-194通过靶向H9c2细胞中的CnA/NFATc2信号通路抑制异丙肾上腺素诱导的慢性心脏肥大。
Ann Transl Med. 2022 Jul;10(14):780. doi: 10.21037/atm-22-1894.
2
Cardiac CaMKII and Wenxin Keli Prevents Ang II-Induced Cardiomyocyte Hypertrophy by Modulating CnA-NFATc4 and Inflammatory Signaling Pathways in H9c2 Cells.心脏钙调蛋白激酶II与稳心颗粒通过调节H9c2细胞中的钙调磷酸酶-NFATc4及炎症信号通路来预防血管紧张素II诱导的心肌细胞肥大。
Evid Based Complement Alternat Med. 2020 Oct 19;2020:9502651. doi: 10.1155/2020/9502651. eCollection 2020.
3
[MicroRNA-133a attenuates isoproterenol-induced neonatal rat cardiomyocyte hypertrophy by downregulating L-type calcium channel α1C subunit gene expression].[微小RNA-133a通过下调L型钙通道α1C亚基基因表达减轻异丙肾上腺素诱导的新生大鼠心肌细胞肥大]
Zhonghua Xin Xue Guan Bing Za Zhi. 2013 Jun;41(6):507-13.
4
Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin/nuclear factor of activated T-cells pathway in rats.康斯他汀通过抑制大鼠心肌肥厚中环核苷酸磷酸二酯酶 5 同工酶/nFAT 通路抑制异丙肾上腺素诱导的心肌肥厚。
Eur J Pharmacol. 2020 Mar 15;871:172849. doi: 10.1016/j.ejphar.2019.172849. Epub 2019 Dec 13.
5
[MicroRNA-23a knockdown attenuates angiotensin Ⅱ induced hypertrophy in rat H9c2 cells via activating PTEN and AMPK pathway].[微小RNA-23a敲低通过激活PTEN和AMPK途径减轻血管紧张素Ⅱ诱导的大鼠H9c2细胞肥大]
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Apr 24;48(4):329-335. doi: 10.3760/cma.j.cn112148-20190513-00244.
6
Semaphorin‑3A alleviates cardiac hypertrophy by regulating autophagy.信号素-3A通过调节自噬减轻心脏肥大。
Exp Ther Med. 2023 Nov 28;27(1):38. doi: 10.3892/etm.2023.12326. eCollection 2024 Jan.
7
MicroRNA-34c-5p provokes isoprenaline-induced cardiac hypertrophy by modulating autophagy targeting ATG4B.微小RNA-34c-5p通过调节靶向自噬相关蛋白4B(ATG4B)的自噬来引发异丙肾上腺素诱导的心肌肥大。
Acta Pharm Sin B. 2022 May;12(5):2374-2390. doi: 10.1016/j.apsb.2021.09.020. Epub 2021 Sep 25.
8
miR-454-3p exerts tumor-suppressive functions by down-regulation of NFATc2 in glioblastoma.miR-454-3p 通过下调 NFATc2 在胶质母细胞瘤中发挥肿瘤抑制功能。
Gene. 2019 Aug 20;710:233-239. doi: 10.1016/j.gene.2019.06.008. Epub 2019 Jun 7.
9
Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.雌激素通过增加钙调神经磷酸酶降解的雌激素受体依赖性途径减轻左心室和心肌细胞肥大。
Circ Res. 2009 Jan 30;104(2):265-75, 11p following 275. doi: 10.1161/CIRCRESAHA.108.190397. Epub 2008 Dec 12.
10
MiRNA-339-5p promotes isoproterenol-induced cardiomyocyte hypertrophy by targeting VCP to activate the mTOR signaling.miRNA-339-5p 通过靶向 VCP 激活 mTOR 信号促进异丙肾上腺素诱导的心肌细胞肥大。
Cell Biol Int. 2022 Feb;46(2):288-299. doi: 10.1002/cbin.11731. Epub 2021 Dec 19.

引用本文的文献

1
Obesity and Heart Failure: Mechanistic Insights and the Regulatory Role of MicroRNAs.肥胖与心力衰竭:机制洞察及微小RNA的调节作用
Genes (Basel). 2025 May 28;16(6):647. doi: 10.3390/genes16060647.
2
Transforming Cardiotoxicity Detection in Cancer Therapies: The Promise of MicroRNAs as Precision Biomarkers.转化型心脏毒性检测在癌症治疗中的应用:MicroRNAs 作为精准生物标志物的前景。
Int J Mol Sci. 2024 Nov 6;25(22):11910. doi: 10.3390/ijms252211910.

本文引用的文献

1
MiR-26a-5p alleviates cardiac hypertrophy and dysfunction via targeting ADAM17.miR-26a-5p 通过靶向作用于 ADAM17 缓解心肌肥厚和功能障碍。
Cell Biol Int. 2021 Nov;45(11):2357-2367. doi: 10.1002/cbin.11685. Epub 2021 Aug 23.
2
Piezo1-Mediated Mechanotransduction Promotes Cardiac Hypertrophy by Impairing Calcium Homeostasis to Activate Calpain/Calcineurin Signaling.Piezo1 介导热激反应促进心脏肥大,其机制是破坏钙稳态以激活钙蛋白酶/钙调磷酸酶信号通路。
Hypertension. 2021 Sep;78(3):647-660. doi: 10.1161/HYPERTENSIONAHA.121.17177. Epub 2021 Aug 2.
3
Hsp90 Inhibitor Attenuates the Development of Pathophysiological Cardiac Fibrosis in Mouse Hypertrophy via Suppression of the Calcineurin-NFAT and c-Raf-Erk Pathways.
热休克蛋白 90 抑制剂通过抑制钙调神经磷酸酶-NFAT 和 c-Raf-Erk 通路减轻小鼠肥厚性心脏病理纤维化的发展。
J Cardiovasc Pharmacol. 2021 Jun 1;77(6):822-829. doi: 10.1097/FJC.0000000000001017.
4
miR-194-5p protects against myocardial ischemia/reperfusion injury via MAPK1/PTEN/AKT pathway.微小RNA-194-5p通过丝裂原活化蛋白激酶1/磷酸酶和张力蛋白同源物/蛋白激酶B信号通路减轻心肌缺血/再灌注损伤。
Ann Transl Med. 2021 Apr;9(8):654. doi: 10.21037/atm-21-807.
5
The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure.丙酮酸-乳酸轴调节心脏肥大和心力衰竭。
Cell Metab. 2021 Mar 2;33(3):629-648.e10. doi: 10.1016/j.cmet.2020.12.003. Epub 2020 Dec 16.
6
MiR-26a-5p inhibits GSK3β expression and promotes cardiac hypertrophy in vitro.微小RNA-26a-5p在体外抑制糖原合成酶激酶3β的表达并促进心肌肥大。
PeerJ. 2020 Nov 17;8:e10371. doi: 10.7717/peerj.10371. eCollection 2020.
7
miR-194-5p negatively regulates the proliferation and differentiation of rabbit skeletal muscle satellite cells.miR-194-5p 负调控兔骨骼肌卫星细胞的增殖和分化。
Mol Cell Biochem. 2021 Jan;476(1):425-433. doi: 10.1007/s11010-020-03918-0. Epub 2020 Sep 30.
8
MiR-194 targets Runx1/Akt pathway to reduce renal fibrosis in mice with unilateral ureteral obstruction.miR-194 通过靶向 Runx1/Akt 通路减少单侧输尿管梗阻小鼠的肾纤维化。
Int Urol Nephrol. 2020 Sep;52(9):1801-1808. doi: 10.1007/s11255-020-02544-5. Epub 2020 Jul 13.
9
The Role of Calcium-Calcineurin-NFAT Signaling Pathway in Health and Autoimmune Diseases.钙调磷酸酶-NFAT 信号通路在健康和自身免疫性疾病中的作用。
Front Immunol. 2020 Mar 10;11:195. doi: 10.3389/fimmu.2020.00195. eCollection 2020.
10
miR-137 and its target T-type Ca 3.1 channel modulate dedifferentiation and proliferation of cerebrovascular smooth muscle cells in simulated microgravity rats by regulating calcineurin/NFAT pathway.miR-137 及其靶标 T 型钙通道通过调节钙调神经磷酸酶/NFAT 通路调节模拟微重力大鼠脑血管平滑肌细胞的去分化和增殖。
Cell Prolif. 2020 Mar;53(3):e12774. doi: 10.1111/cpr.12774. Epub 2020 Feb 8.